Renal Drugs Market adoption in the US is encouraged by advances in clinical management and the use of medications designed to slow disease progression in eligible patients. The Renal Drugs Market was valued at US$ 21.16 billion in 2025 and is projected to reach US$ 35.05 billion by 2034, registering a CAGR of 5.77% during the forecast period from 2026 to 2034. Market growth is supported by the...